Welcome to Cleveland Clinic Online Health Chats

Get answers to your health questions and concerns. It's easy to be part of our live chat events, led by Cleveland Clinic physicians and health professionals.

Lung Cancer Awareness
Thursday, November 15, 2018 - 12 Noon (Eastern Time)

Sign up for this chat today.Register Now

Click Join Chat to join the chat in progress.You will be asked to login if you aren't already logged in.Join Chat

Usman Ahmad, MD

  • Thoracic Surgeon

Peter Mazzone, MD, MPH

  • Pulmonologist

Gregory Videtic, MD

  • Radiation Oncologist

Lung cancer can be a very challenging cancer to treat. The most critical factor in determining the survival rate is the stage at the time of diagnosis. Using a multidisciplinary approach to lung cancer care is vital to managing the disease. Take this opportunity to have your questions answered by thoracic surgeon Usman Ahmad, MD, pulmonologist, Peter Mazzone, MD, MPH, and radiation oncologist, Gregory Videtic, MD.

November is Lung Cancer Awareness Month. Using a multidisciplinary approach to lung cancer care is vital to managing the disease. Our comprehensive Lung Cancer Program at Cleveland Clinic includes a multidisciplinary team of medical oncologists, pulmonologists, radiation oncologists, pathologists, thoracic surgeons, and thoracic radiologists who collaborate to provide customized, coordinated care for patients. This allows us to focus our entire team’s expertise and energy on providing the best outcomes for our patients. While there is no one solution for treating lung cancer, there are many options.

Like other cancers, lung cancer develops when normal processes of cell division and growth are disrupted, giving way to abnormal, uncontrollable growth. The cells grow into a mass, or tumor. Any abnormal growth in the body that directly invades surrounding tissues and organs, spreads to other parts of the body, or has the potential to grow back after being removed is called “malignant,” or cancerous.

Usman Ahmad, MD, is a thoracic surgeon in the Department of Thoracic and Cardiovascular Surgery at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He holds a joint appointment with the Taussig Cancer Institute. Dr. Ahmad is board-certified in surgery. He joined Cleveland Clinic in 2015. His specialty interests include thoracic oncology; lung cancer; esophageal cancer; tracheal tumors; thymic tumors; chest wall tumors; minimally invasive thoracic surgery, including robotic, thorascopic, laparoscopic and bronchoscopic procedures; cancer outcomes; and general thoracic surgery

Peter Mazzone, MD, MPH, is Director of the Lung Cancer Program and Lung Cancer Screening Program within the Respiratory Institute. Dr. Mazzone is board-certified in internal medicine, pulmonary medicine and critical care medicine. His specialty interests include lung nodules, lung cancer and intensive care unit medicine. His research interests focus on breath analysis, lung cancer diagnostics, lung nodule evaluation, lung physiology assessment and lung cancer screening.

Gregory Videtic, MD, CM, FRCPC, received his medical degree from McGill University Faculty of Medicine in Montreal, Quebec, Canada. He completed a first residency in family medicine at Dalhousie University in Halifax, Nova Scotia. He later carried out a clinical research fellowship in geriatrics at the University of Western Ontario, London, Ontario. His specialty interests include radioprotectants, radiosensitizers, stereotactic body radiotherapy, altered fractionation and treatment toxicity.

This Health Chat is currently open to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.